SCHEMBL6574407

SCHEMBL6574407

CC1(C)CCN(c2ccccc2)c2cc(Br)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.42
PDE4B Q07343 1/20 0.42
GABRA1 P14867 1/20 0.40
GABRB2 P47870 1/20 0.40
ALDH1A1 P00352 2/20 0.39
SIGMAR1 Q99720 1/20 0.34
RXRA P19793 1/20 0.34
RXRB P28702 1/20 0.34
RXRG P48443 1/20 0.34
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
BRD2 P25440 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
MAPT P10636 3/20 0.33
CYP3A4 P08684 2/20 0.33
KDM4E B2RXH2 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6578064 0.87 HTR2B (0.34) HSD11B1PDE4BGABRA1GABRB2ALDH1A1
SCHEMBL6578033 0.79 RARA (0.40) HSD11B1GABRA1GABRB2SIGMAR1RXRA
SCHEMBL6578008 0.79 RARB (0.51) CYP3A4RARARARBRARG
SCHEMBL20061936 0.78 HSD11B1 (0.38) HSD11B1SIGMAR1RXRARXRBRXRG
SCHEMBL9143502 0.76 GABRA1 (0.38) PDE4BGABRA1GABRB2ALDH1A1SIGMAR1
SCHEMBL8616759 0.75 RARB (0.42) HSD11B1GABRA1RXRARXRBRXRG
SCHEMBL24011964 0.73 MAP3K14 (0.51) ALDH1A1SIGMAR1LMNAMAPK1L3MBTL1
SCHEMBL7712301 0.73 RARA (0.53) HSD11B1PDE4BGABRA1GABRB2SIGMAR1
SCHEMBL6574370 0.72 RARB (0.67) RXRACYP3A4RARARARBRARG
SCHEMBL9593391 0.71 RARB (0.38) GABRA1GABRB2ALDH1A1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0937045-B1 N-ARYL SUBSTITUTED TETRAHYDROQUINOLINES LIGANDS FOR RETINOID RECEPTORS HAVING AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE ACTIVITY ALLERGAN INC (US) 2004-04-28 EP disclosed
EP-0937045-A1 N-ARYL SUBSTITUTED TETRAHYDROQUINOLINES LIGANDS FOR RETINOID RECEPTORS HAVING AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE ACTIVITY Allergan Sales, Inc. (US) 1999-08-25 EP disclosed
WO-1998019999-A1 N-ARYL SUBSTITUTED TETRAHYDROQUINOLINES LIGANDS FOR RETINOID RECEPTORS HAVING AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE ACTIVITY ALLERGAN SALES, INC. (US) 1998-05-14 WO disclosed
US-5739338-A SKIN DISORDERS, ANTIINFLAMMATORY AGENTS, ANTITUMOR AGENTS, VISION DEFECTS, VIRICIDES, IMMUNOSUPPRESSANTS ALLERGAN (US) 1998-04-14 US disclosed